Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
10/2012
10/25/2012US20120270858 Isoquinoline, quinoline, and quinazoline derivatives as inhibitors of hedgehog signaling
10/25/2012US20120270856 Heteroaryloxy quinazoline derivatives
10/25/2012US20120270853 Arylpropionamide, arylacrylamide, arylpropynamide, or arylmethylurea analogs as factor xia inhibitors
10/25/2012US20120270852 Phenyl or pyridinyl-ethynyl derivatives
10/25/2012US20120269864 Arginine Derivatives with NP-I Antagonistic Activity
10/24/2012EP2514750A1 Bromo-phenyl substituted thiazolyl dihydropyrimidines
10/24/2012EP2514749A1 Oxadiazole derivative having endothelial lipase inhibitory activity
10/24/2012EP2514748A1 2,4-diaminoquinazolines for spinal muscular atrophy
10/24/2012EP2513095A1 Oxadiazole substituted indazole derivatives for use as sphingosine 1-phosphate 1 (s1p1) receptor agonists
10/24/2012EP2513090A1 Compound suitable for the treatment of synucleopathies
10/24/2012EP2513069A1 Antifungal compounds
10/24/2012EP2513068A1 Substituted benzothiazole and benzoxazole derivatives useful as inhibitors of dpp-1
10/24/2012EP2513061A1 Pyridone derivatives as nk3 antagonists
10/24/2012EP2513053A1 Pyrrolidine or thiazolidine carboxylic acid derivatives, pharmaceutical composition and methods for use in treating metabolic disordersas as agonists of g- protein coupled receptor 43 (gpr43)
10/24/2012EP2513052A1 Pyrrolidine derivatives
10/24/2012EP2512474A1 N-linked hydroxamic acid derivatives useful as antibacterial agents
10/24/2012EP2512243A1 Quinoline amide m1 receptor positive allosteric modulators
10/24/2012CN102753546A A novel 5-membered heterocycle derivatives and manufacturing process thereo
10/24/2012CN102753545A Oxadiazole derivative having endothelial lipase inhibitory activity
10/24/2012CN102753537A Method for the preparation of rivaroxaban
10/24/2012CN102753535A Quinazolines as potassium ion channel inhibitors
10/24/2012CN102746297A Oxazolidinone antibiotics
10/24/2012CN102746296A Oxazolidinone antibiotics
10/24/2012CN102746288A Preparation methods of anticoagulant and key intermediate of anticoagulant
10/24/2012CN102746287A Oxazolidinone compound and preparation method thereof
10/24/2012CN102746286A Benzo-dioxazole and preparation method thereof
10/24/2012CN102746285A Compounds and compositions as HEDGEHOG pathway modulators
10/24/2012CN102746253A Oxadiazole derivative containing veratraldehyde and preparation method thereof
10/24/2012CN102746214A Novel indoline compounds
10/24/2012CN102744106A Palladium catalyst for catalyzing Suzuki coupling reaction, synthesis method, application and ligand
10/23/2012US8293920 Synthesis of enone intermediate
10/23/2012US8293897 Compounds comprising a spiro-ring and methods of use
10/23/2012US8293769 CSF-1R inhibitors, compositions, and methods of use
10/23/2012US8293765 Injectable depot formulation comprising crystals of iloperidone
10/23/2012US8293752 Compounds useful as Raf kinase inhibitors
10/23/2012US8293751 1,2,3-trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia
10/23/2012US8293747 Heterocyclic amide compounds as protein kinase inhibitors
10/23/2012US8293740 Sigma receptor inhibitors
10/23/2012US8293738 Indazole inhibitors of kinase
10/23/2012US8293737 Anxiolytic compounds
10/23/2012US8293736 Purine compounds selective for PI3K P110 delta, and methods of use
10/23/2012US8293735 Thienopyrimidine derivatives as P13K inhibitors
10/23/2012US8293729 Compounds, pharmaceutical composition and methods relating thereto
10/23/2012US8293721 CETP inhibitors derived from benzoxazole arylamides
10/23/2012US8293145 Optical film
10/23/2012CA2736751C Salts of n-[6-(cis-2,6-dimethylmorpholin-4-yl)pyridine-3-yl]-2-methyl-4'-(trifluoromethoxy)[1,1'-biphenyl]-3-carboxamide
10/23/2012CA2488635C Antagonists of melanin concentrating hormone receptor
10/23/2012CA2441410C Compounds and method of treatment having agonist-like activity selective at alpha 2b or 2b/2c adrenergic receptors
10/18/2012WO2012142513A1 Substituted benzene compounds
10/18/2012WO2012142504A1 Aryl-or heteroaryl-substituted benzene compounds
10/18/2012WO2012141487A2 Cycloalkenyl aryl derivatives for cetp inhibitor
10/18/2012WO2012140596A1 Glycoside derivatives and uses thereof
10/18/2012WO2012140419A1 Chromenone compounds as pi 3 -kinase inhibitors for the treatment of cancer
10/18/2012WO2012140061A1 Method for the preparation of substituted oxazolidinones
10/18/2012WO2012140020A1 Novel piperidinyl monocarboxylic acids as s1p1 receptor agonists
10/18/2012WO2012140001A1 Use of substituted dithiine-dicarboximides for combating phytopathogenic fungi
10/18/2012WO2012139993A1 1,3 oxazines as bace1 and/or bace2 inhibitors
10/18/2012WO2012139930A1 Pyrazolyl-pyrimidine derivatives as kinase inhibitors
10/18/2012WO2012139536A1 A method of preparing 2-ethoxy-1-((2'-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)biphenyl- 4-yl)methyl)-1h-benzo[d]imidazole-7-carboxylates and conversion thereof to azilsartan
10/18/2012WO2012139535A1 A method of preparing 2-ethoxy-1-((2'-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)biphenyl- 4-yl)methyl)-1h-benzo[d]imidazole-7-carboxylates and conversion thereof to azilsartan
10/18/2012WO2012139499A1 Urea compounds as well as preparation methods, intermediates and uses thereof
10/18/2012WO2012113850A3 (PYRIDIN-4-YL)BENZYLAMIDES AS ALLOSTERIC MODULATORS OF ALPHA 7 nAChR
10/18/2012WO2012094622A3 Amination of aryl alcohol derivatives
10/18/2012US20120264934 Salt forms of [R-(R*,R*)]-2-(4-flurorophenyl)-beta, delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid
10/18/2012US20120264909 Phosphorous containing benzoxazine-based monomer, polymer thereof, electrode for fuel cell including the same, electrolyte membrane for fuel cell including the same, and fuel cell employing the same
10/18/2012US20120264801 5-membered heterocycle-based p38 kinase inhibitors
10/18/2012US20120264792 Furazanobenzimidazoles as prodrugs to treat neoplastic or autoimmune diseases
10/18/2012US20120264761 Aminobenzoquinazolinone M1 Receptor Positive Allosteric Modulators
10/18/2012US20120264755 Pyridinyl derivatives as inhibitors of enzyme nicotinamide phosphoribosyltransferase
10/18/2012US20120264753 Novel 1-(biphenyl-4-yl-methyl)-1h-imidazole derivative and pharmaceutical product containing same
10/18/2012US20120264752 Dual-acting antihypertensive agents
10/18/2012US20120264736 Benzenesulfonyl-chromane, thiochromane, tetrahydronaphthalene and related gamma secretase inhibitors
10/18/2012US20120264735 Tyrosine kinase inhibitors
10/18/2012US20120264734 Aryl- or Heteroaryl-Substituted Benzene Compounds
10/18/2012US20120264733 Heterocyclic compound and use thereof
10/18/2012US20120264731 Chromenone derivatives
10/18/2012US20120264729 Co-crystals and salts of ccr3-inhibitors
10/18/2012US20120264717 Compounds, Compositions and Methods Comprising Oxadiazole Derivatives
10/18/2012US20120264704 Substituted dihydropyrazolones and use thereof as hif-prolyl-4 -hydroxylase inhibitors
10/18/2012US20120263708 Substituted aminoquinoxalines as tyrosine threonine kinase inhibitors
10/18/2012US20120263679 Combinations Comprising Heterocyclic Inhibitors of MEK and Methods of Use Thereof
10/18/2012US20120263659 Use of physiological cooling active ingredients, and agents containing such active ingredients
10/18/2012CA2833180A1 Novel piperidinyl monocarboxylic acids as s1p1 receptor agonists
10/18/2012CA2832951A1 Glycoside derivatives and uses thereof
10/18/2012CA2832846A1 Substituted benzene compounds
10/18/2012CA2832843A1 Aryl-or heteroaryl-substituted benzene compounds
10/18/2012CA2832787A1 Chromenone compounds as pi 3 - kinase inhibitors for the treatment of cancer
10/18/2012CA2832467A1 1,3 oxazines as bace1 and/or bace2 inhibitors
10/18/2012CA2829676A1 Cycloalkenyl aryl derivatives for cetp inhibitor
10/17/2012EP2511275A1 Novel piperidinyl monocarboxylic acids as S1P1 receptor agonists
10/17/2012EP2511268A1 Oxazine derivative
10/17/2012EP2509977A1 Novel cationic 4-aminoindoles, dye composition comprising a cationic 4-aminoindole, processes therefor and uses thereof
10/17/2012EP2509975A1 Benzimidazole inhibitors of leukotriene production
10/17/2012EP2509966A1 Amino oxazine derivatives
10/17/2012EP2509965A1 2-amino-5, 5-difluoro-5, 6-dihydro-4h-oxazines as bace 1 and/or bace 2 inhibitors
10/17/2012EP2509955A1 Pyrazole derivatives as modulators of calcium release -activated calcium channel
10/17/2012EP2509954A1 4 -oxo- 1h -quinoline- 3 - carboxamides as modulators of atp -binding cassette transporters
10/17/2012EP2509951A1 Novel cationic aminopyridines, dye composition comprising a cationic aminopyridine, processes therefor and uses thereof
10/17/2012EP2509946A1 Spiro indole - cyclopropane indolinones useful as ampk modulators
10/17/2012EP2509424A1 Novel oxadiazole compounds
1 ... 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 ... 647